Sequoia and Greenoaks lead Isomorphic Labs $5B Series C
Isomorphic Labs announced that it has raised $5 billion in a Series C funding round. The round was co-led by Greenoaks and Sequoia Capital alongside Andreessen Horowitz and Alphabet, with participation from existing investors. The company focuses on designing new medicines with AI and is scaling its proprietary drug design engine and therapeutic candidate pipeline. Open article →